Novelty of Axin 2 and lack of Axin 1 gene mutation in colorectal cancer: A study in Kashmiri population

Molecular and Cellular Biochemistry

Volumn 355, Issue 1-2, 2011, Pages 149-155

  Khan, Nighat P ^a   Pandith, Arshad A ^a   Hussain, Mahboob Ul ^b   Yousuf, Adfar ^a   Khan, Mosin S ^a   Wani, Khursheed A ^a   Mudassar, Syed ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF KASHMIR   (India)

Author keywords

Axin; Colorectal carcinoma; Kashmiri population; Mutation

Indexed keywords

AXIN; AXIN 1; AXIN 2; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CODON; COLORECTAL CARCINOMA; DISEASE COURSE; DISEASE PREDISPOSITION; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INDIA; MALE; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADENOCARCINOMA; ADULT; AGED; AXIN PROTEIN; BASE SEQUENCE; COLORECTAL NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MALE; MIDDLE AGED; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA;

EID: 80051546779     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0848-8     Document Type: Article

References (29)

1. American Cancer Society. Cancer Facts & Figures 2010. American Cancer Society, Atlanta
2. R Kumar P Mende CD Wacker B Spiegelhalder R Preussmann M Siddiqi 1992 Caffeine-derived N-nitroso compounds-I: nitrosatable precursors from caffeine and their potential relevance in the etiology of oesophageal and gastric cancers in Kashmir, India Carcinogenesis 13 2179 2182 1330353 10.1093/carcin/13.11.2179 1:CAS:528:DyaK3sXnvFKmsw%3D%3D
3. Gregory LB, Russell GR (2006) Colorectal Cancer Risk Factors. Colorectal Cancer. Armenian Health Network, Health.am. http://www.health.am/cr/colorectal- cancer/. Retrieved 16 Jan 2008
4. B Vogelstein ER Fearon SR Hamilton SE Kem AC Preisinger M Lepper Y Nakamura R White AMM Smits IL Bos 1988 Genetic alterations during colorectal tumor development N Engl Med 319 525 532 10.1056/NEJM198809013190901 1:STN:280:DyaL1czgt1aqtQ%3D%3D
5. X Hong-Tao W Qiang L Yang Y Lian-He D Shun-Dong H Yang Y Juan-Han L Nan W En-Hua 2007 Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer Ann Surg Oncol 14 3251 3259 10.1245/s10434-007-9555-9 (Pubitemid 47594295)
6. S Salahshor JR Woodgett 2005 The links between axin and carcinogenesis J Clin Pathol 58 225 236 15735151 10.1136/jcp.2003.009506 1:CAS:528: DC%2BD2MXjtVKhsLo%3D (Pubitemid 40380314)
7. J Massague 1998 TGF-beta signal transduction Annu Rev Biochem 67 753 791 9759503 10.1146/annurev.biochem.67.1.753 1:CAS:528:DyaK1cXlsFOmsbY%3D (Pubitemid 28411144)
8. M Furuhashi K Yagi H Yamamoto, et al. 2001 Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway Mol Cell Biol 21 5132 5141 11438668 10.1128/MCB.21.15.5132-5141.2001 1:CAS:528: DC%2BD3MXlsVGitLc%3D (Pubitemid 32656409)
9. M Nishita MK Hashimoto S Ogata, et al. 2000 Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer Nature 403 781 785 10693808 10.1038/35001602 1:CAS:528:DC%2BD3cXhsVWitrc%3D (Pubitemid 30111840)
10. YT Ip RJ Davis 1998 Signal transduction by the c-Jun N-terminal kinase (JNK) from inflammation to development Curr Opin Cell Biol 10 205 219 9561845 10.1016/S0955-0674(98)80143-9 1:CAS:528:DyaK1cXisFyntLo%3D (Pubitemid 28174763)
11. Y Zhang SY Neo X Wang, et al. 1999 Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling J Biol Chem 274 35247 35254 10575011 10.1074/jbc.274.49.35247 1:CAS:528:DyaK1MXnvFyru74%3D (Pubitemid 129509583)
12. Y Zhang SY Neo J Han, et al. 2000 Dimerization choices control the ability of axin and dishevelled to activate c-Jun N-terminal kinase/stress-activated protein kinase J Biol Chem 275 25008 25014 10829020 10.1074/jbc.M002491200 1:CAS:528:DC%2BD3cXlsl2jtbg%3D (Pubitemid 30626610)
13. SY Neo Y Zhang LP Yaw, et al. 2000 Axin-induced apoptosis depends on the extent of its JNK activation and its ability to down-regulate beta-catenin levels Biochem Biophys Res Commun 272 144 150 10872818 10.1006/bbrc.2000.2751 1:CAS:528:DC%2BD3cXkt1ansL0%3D (Pubitemid 30444913)
14. MT Webster M Rozycka E Sara, et al. 2000 Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding Genes Chromosomes Cancer 28 443 453 10862053 10.1002/1098-2264(200008)28:4<443::AID-GCC10>3.0.CO;2-D 1:CAS:528:DC%2BD3cXlsFSisLw%3D (Pubitemid 30451797)
15. R Wu Y Zhai ER Fearon KR Cho 2001 Diverse mechanisms of betacatenin deregulation in ovarian endometrioid adenocarcinomas Cancer Res 61 8247 8255 11719457 1:CAS:528:DC%2BD3MXovVShsb4%3D (Pubitemid 33091619)
16. S Satoh Y Daigo Y Furukawa T Kato N Miwa T Nishiwaki T Kawasoe H Ishiguro M Fujita T Tokino Y Sasaki S Imaoka, et al. 2000 AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 Nat Genet 24 245 250 10700176 10.1038/73448 1:CAS:528:DC%2BD3cXhvFaqtrY%3D (Pubitemid 30132191)
17. K Taniguchi LR Roberts IN Aderca X Dong C Qian LM Murphy DM Nagorney LJ Burgart PC Roche DI Smith JA Ross W Liu 2002 Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas Oncogene 21 4863 4871 12101426 10.1038/sj.onc.1205591 1:CAS:528:DC%2BD38XltVOmu7w%3D (Pubitemid 34879463)
18. J Li-Hua S Qiu-Jie L Wen YE Zhi-Yun L Qing L Sheng-Cai 2003 Detection of point mutations of the Axin1 gene in colorectal cancers Int J Cancer 107 696 699 10.1002/ijc.11435 (Pubitemid 37339721)
19. K Matthias C Cristian T Frank G Helga M Sonja H von Arndt G Karl P Göran P Maja P Svante 2000 Mutation of Axin 2 causes colorectal cancer with defective mismatch repair by activating b-catenin/tcf signaling Nat Genet 26 2 146 147 10.1038/79859
20. T Lin EL Guro L Tone BD Chieu IM Gunn OR Torleiv AL Ragnhild 2005 Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability Neoplasia 7 2 99 108 10.1593/neo.04448 (Pubitemid 40315987)
21. L Wen L Sheng-Caim 2004 Axin: a master scaffold for multiple signaling pathways Neurosignals 13 99 113 10.1159/000076563 (Pubitemid 38456651)
22. M Peifer P Polakis 2000 Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus Science 287 1606 1609 10733430 10.1126/science.287. 5458.1606 1:CAS:528:DC%2BD3cXhs1OrtLs%3D (Pubitemid 30127755)
23. MT Webster M Rozycka E Sara 2000 Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding Genes Chromosomes Cancer 28 443 453 10862053 10.1002/1098- 2264(200008)28:4<443::AID-GCC10>3.0.CO;2-D 1:CAS:528:DC%2BD3cXlsFSisLw%3D (Pubitemid 30451797)
24. K Söreide EA Janssen H Soiland H Korner JP Baak 2006 Microsatellite instability in colorectal cancer Br J Surg 93 395 406 16555243 10.1002/bjs.5328
25. W Luo WW Ng LH Jin Z Ye J Han SC Lin 2003 Axin utilizes distinct regions for competitive MEKK1 and MEKK4 binding and JNK activation J Biol Chem 278 37451 37458 12878610 10.1074/jbc.M305277200 1:CAS:528:DC%2BD3sXnsV2ls7s%3D (Pubitemid 37175265)
26. M Furuhashi K Yagi H Yamamoto Y Furukawa S Shimada Y Nakamura A Kikuchi K Miyazono M Kato 2001 Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway Mol Cell Biol 21 5132 5141 11438668 10.1128/MCB.21.15.5132-5141.2001 1:CAS:528:DC%2BD3MXlsVGitLc%3D (Pubitemid 32656409)
27. CH Heldin K Miyazono P ten Dijke 1997 TGF-beta signalling from cell membrane to nucleus through SMAD proteins Nature 390 465 471 9393997 10.1038/37284 1:CAS:528:DyaK2sXnvFyrtLo%3D (Pubitemid 28013118)
28. MP de Caestecker E Piek AB Roberts 2000 Role of transforming growth factor-beta signaling in cancer J Natl Cancer Inst 92 17 1388 1402 10974075 10.1093/jnci/92.17.1388
29. S LeppaÈ B Dirk 1999 Diverse functions of JNK signaling and c-Jun in stress response and apoptosis Oncogene 18 6158 6162 10.1038/sj.onc.1203173